Azithromycin for primary ciliary dyskinesia: a milestone

Lancet Respir Med. 2020 May;8(5):429-430. doi: 10.1016/S2213-2600(20)30100-4.

Authors

Marco Poeta¹, Melissa Borrelli¹, Francesca Santamaria²

Affiliations

¹ Department of Translational Medical Sciences, Section of Pediatrics, Federico II University, 80131 Naples, Italy.
² Department of Translational Medical Sciences, Section of Pediatrics, Federico II University, 80131 Naples, Italy. Electronic address: santamar@unina.it.

PMID: 32380064
DOI: 10.1016/S2213-2600(20)30100-4

No abstract available

Publication types

Comment

MeSH terms

Azithromycin*
Ciliary Motility Disorders*
Double-Blind Method
Humans

Substances

Azithromycin